Sunday, 27 December 2015

Roche Media Academy Wins Silver in the Healthcare and Services category at the MEPRA Awards 2015

An “Empowerment Through Knowledge” initiative launched by Roche UAE to link media to the world of healthcare and create informed masses by encouraging higher disease awareness
Dubai, United Arab Emirates, December 23, 2015: The Roche Media Academy initiative won the Silver Award in Healthcare and Services category at the Middle East Public Relations Association Awards (MEPRA) 2015.
Launched by Roche UAE in 2014, the Roche Media Academy is an “Empowerment Through Knowledge” initiative, aimed at equipping journalists with accurate information on how diseases affect the lives of patients. Through interactive sessions, it brings together leading healthcare experts from the UAE and journalists from the region to empower them and enhance their knowledge on medical subjects. Sessions cover common, yet less talked about diseases, with an endeavor to support the important role played by the media in raising public awareness on national health concerns.
“We are very pleased and humbled by the recognition that the Roche Media Academy initiative has received. In alignment with our objectives, we hope to continue our efforts in raising awareness on critical diseases to improve the lives of patients and build healthier societies.” expressed Abed Sabra, Country Manager, Roche UAE.
The MEPRA Awards is a leading public relations awards program in the Middle East, recognizing best in class campaigns in various practices, including healthcare.
About Roche:
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-four medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, anti-malarials and chemotherapy.
In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit
All trademarks used or mentioned in this release are protected by law.